Caricamento...
MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer
BACKGROUND: The methylation of microtubule-associated protein tau (MAPT) was first described in patients with Alzheimer’s disease. In this study, we aim to determine if MAPT promoter CpG island is hypermethylated and whether this signature could work as a prognostic marker for patients with stage II...
Salvato in:
| Pubblicato in: | Cancer Manag Res |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6689138/ https://ncbi.nlm.nih.gov/pubmed/31496795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S206731 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|